中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 10
Oct.  2022
Turn off MathJax
Article Contents

Role and mechanism of caffeic acid phenethyl ester in hepatic stellate cell

DOI: 10.3969/j.issn.1001-5256.2022.10.014
Research funding:

Shaanxi Key Research and Development Project (2021SF-227);

Fundamental Research Funds for the Central Universities (xjh012019063)

More Information
  • Corresponding author: SHI Juanjuan, shijuan0307@163.com(ORCID: 0000-0002-5626-9821)
  • Received Date: 2022-03-15
  • Accepted Date: 2022-04-21
  • Published Date: 2022-10-20
  •   Objective  To assess the effect and underlying molecular events of caffeic acid phenethyl ester (CAPE) on rat hepatic stellate HSC-T6 cells.  Methods  HSC-T6 cells were grown and treated with different concentrations of CAPE (5, 10, or 15 μmol/L), transfected with or without LC3-GFP plasmid, and then treated with or without an autophagy inducer rapamycin or the autophagy inhibitor 3-methyladenine (3-MA). The changed cell viability and morphology were assessed by using cell viability MTT assay and Transmission electron microscope, respectively. The expression of LC3 protein in HSC-T6 cells was detected by immunofluorescence assay, the autophagy-related genes expression of ATG5, ATG7, ATG12, Beclin1 and LC3 were detected by qRT-PCR, and the expression of ATG7, Beclin1, LC3I/Ⅱ, p-AKT/AKT, p-mTOR protein was detected by Western-blot. Comparison between multiple groups was analyzed by one-way ANOVA with Dunnett t-test.  Results  Compared with the control, CAPE treatment significantly reduced cell viability but induced formation of lipid droplets and roulette-shaped autophagosomes. Compared with the control (13.34%±2.59), LC3 protein was significantly induced in HSC-T6 cells after CAPE treatment (5 μmol/L, 23.68%±3.76, t=-5.553, P < 0.001; 10 μmol/L, 43.47%±3.83, t=-15.958, P < 0.001; 15 μM, 57.25%±2.78, t=-28.334, P < 0.001), while levels of ATG5, ATG7, ATG12, Beclin 1, and LC3 mRNAs were all significantly increased in 10 μm and 15 μm CAPE treated cells vs the control (all P < 0.05). After LC3 overexpression in HSC-T6 cells, LC3 protein was induced vs the vector control (79.01%±6.69% vs 67.06%±6.74%, t=-3.083, P=0.012), while rapamycin treatment further increased LC3 expression (86.88%±5.42%, t=-2.239, P=0.049); however, 3-MA treatment significantly decreased LC3 expression in cells (71.22%±4.29%, t=-2.404, P=0.037). In addition, levels of ATG7, Beclin1, and LC3 Ⅰ/Ⅱ proteins were increased, whereas levels of AKT/p-AKT and p-mTOR were decreased in the CAPE and rapamycin groups vs controls. However, the 3-MA treatment had an opposite result, indicating that 3-MA reversed CAPE-induced effects in HSC-T6 cells.  Conclusion  Caffeic acid phenethyl ester may induce autophagy to reduce cell viability in hepatic stellate cells by inhibition of the AKT/mTOR signaling.

     

  • loading
  • [1]
    MURTAZA G, KARIM S, AKRAM MR, et al. Caffeic acid phenethyl ester and therapeutic potentials[J]. Biomed Res Int, 2014, 2014: 145342. DOI: 10.1155/2014/145342.
    [2]
    OLGIERD B, KAMILA Z, ANNA B, et al. The pluripotent activities of caffeic acid phenethyl ester[J]. Molecules, 2021, 26(5): 1335. DOI: 10.3390/molecules26051335.
    [3]
    LI M, WANG XF, SHI JJ, et al. Caffeic acid phenethyl ester inhibits liver fibrosis in rats[J]. World J Gastroenterol, 2015, 21(13): 3893-3903. DOI: 10.3748/wjg.v21.i13.3893.
    [4]
    YANG N, SHI JJ, WU FP, et al. Caffeic acid phenethyl ester up-regulates antioxidant levels in hepatic stellate cell line T6 via an Nrf2-mediated mitogen activated protein kinases pathway[J]. World J Gastroenterol, 2017, 23(7): 1203-1214. DOI: 10.3748/wjg.v23.i7.1203.
    [5]
    HAZARI Y, BRAVO-SAN PEDRO JM, HETZ C, et al. Autophagy in hepatic adaptation to stress[J]. J Hepatol, 2020, 72(1): 183-196. DOI: 10.1016/j.jhep.2019.08.026.
    [6]
    KOUROUMALIS E, VOUMVOURAKI A, AUGOUSTAKI A, et al. Autophagy in liver diseases[J]. World J Hepatol, 2021, 13(1): 6-65. DOI: 10.4254/wjh.v13.i1.6.
    [7]
    ALLAIRE M, RAUTOU PE, CODOGNO P, et al. Autophagy in liver diseases: Time for translation?[J]. J Hepatol, 2019, 70(5): 985-998. DOI: 10.1016/j.jhep.2019.01.026.
    [8]
    ROEHLEN N, CROUCHET E, BAUMERT TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives[J]. Cells, 2020, 9(4): 875. DOI: 10.3390/cells9040875.
    [9]
    KISSELEVA T, BRENNER D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 151-166. DOI: 10.1038/s41575-020-00372-7.
    [10]
    LEVINE B, KROEMER G. Biological functions of autophagy genes: a disease perspective[J]. Cell, 2019, 176(1-2): 11-42. DOI: 10.1016/j.cell.2018.09.048.
    [11]
    WANG H, LIU Y, WANG D, et al. The upstream pathway of mTOR-mediated autophagy in liver diseases[J]. Cells, 2019, 8(12): 1597. DOI: 10.3390/cells8121597.
    [12]
    LEE KW, THIYAGARAJAN V, SIE HW, et al. Synergistic effect of natural compounds on the fatty acid-induced autophagy of activated hepatic stellate cells[J]. J Nutr Biochem, 2014, 25(9): 903-913. DOI: 10.1016/j.jnutbio.2014.04.001.
    [13]
    PARK M, KIM YH, WOO SY, et al. Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation[J]. Sci Rep, 2015, 5: 8616. DOI: 10.1038/srep08616.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(2)

    Article Metrics

    Article views (399) PDF downloads(37) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return